Dystroglycan: Emerging roles in mammary gland function

Journal of Mammary Gland Biology and Neoplasia

Volumn 8, Issue 4, 2003, Pages 409-419

  Weir, M Lynn ^a   Muschler, John ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Breast; Carcinoma; Dystroglycan; Epithelial; Laminin; Mammary

Indexed keywords

ACTIN; AGRIN; AMINO ACID; BIGLYCAN; DYSTROGLYCAN; GLYCOPROTEIN; LAMININ 1; LIGAND; MEMBRANE PROTEIN; MEROSIN; PERLECAN; PROTEIN SH2; PROTEIN SUBUNIT;

ALPHA CHAIN; BASEMENT MEMBRANE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; COMPLEX FORMATION; CYTOPLASM; CYTOSKELETON; HUMAN; LIGAND BINDING; MAMMARY GLAND; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; DYSTROGLYCANS; EPITHELIUM; HUMANS; LIGANDS; MAMMARY GLANDS, ANIMAL; MEMBRANE GLYCOPROTEINS; NEOPLASMS;

EID: 4344637856     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOMG.0000017428.38034.a7     Document Type: Review

References (81)

1. M. L. Li, J. Aggeler, D. A. Farson, C. Hatier, J. Hassell, and M. J. Bissell (1987). Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc. Natl. Acad. Sci. US.A. 84:136-140.
2. M. H. Barcellos-Hoff, J. Aggeler, T. G. Ram, and M. J. Bissell (1989). Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105:223-235.
3. C. H. Streuli, C. Schmidhauser, N. Bailey, P. Yurchenco, A. P. Skubitz, C. Roskelley, and M. J. Bissell (1995). Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129:591-603.
4. J. Muschler, A. Lochter, C. D. Roskelley, P. Yurchenco, and M. J. Bissell (1999). Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol. Biol. Cell 10:2817-2828.
5. M. J. Bissell, D. C. Radisky, A. Rizki, V. M. Weaver, and O. W. Petersen (2002). The organizing principle: Microenvironmental influences in the normal and malignant breast. Differentiation 70:537-546.
6. J. Muschler, D. Levy, R. Boudreau, M. Henry, K. Campbell, and M. J. Bissell (2002). A role for dystroglycan in epithelial polarization: Loss of function in breast tumor cells. Cancer Res. 62:7102-7109.
7. W. F. Vogel, A. Aszodi, F. Alves, and T. Pawson (2001). Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol. Cell Biol. 21:2906-2917.
8. J. F. Talts, Z. Andac, W. Gohring, A. Brancaccio, and R. Timpl (1999). Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, suffatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J. 18:863-870.
9. J. M. Ervasti and K. P. Campbell (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:809-823.
10. S. Sugita, F. Saito, J. Tang, J. Satz, K. Campbell, and T. C. Sudhof (2001). A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 154:435-445.
11. S. H. Gee, F. Montanaro, M. H. Lindenbaum, and S. Carbonetto (1994). Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77:675-686.
12. M. A. Bowe, D. B. Mendis, and J. R. Fallon (2000). The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J. Cell Biol. 148:801-810.
13. H. B. Peng, A. A. Ali, D. F. Daggett, H. Rauvala, J. R. Hassell, and N. R. Smalheiser (1998). The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes. Commun. 5:475-489.
14. Y. Sunada, S. M. Bernier, C. A. Kozak, Y. Yamada, and K. P. Campbell (1994). Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J. Biol. Chem. 269:13729-13732.
15. D. E. Michele and K. P. Campbell (2003). Dystrophin-glycoprotein complex: Posttranslational processing and dystroglycan function. J. Biol. Chem. 278:15457-15460.
16. M. Durbeej and K. P. Campbell (2002). Muscular dystrophies involving the dystrophin-glycoprotein complex: An overview of current mouse models. Curr. Opin. Genet. Dev. 12:349-361.
17. J. M. Ervasti, K. Ohlendieck, S. D. Kahl, M. G. Gaver, and K. P. Campbell (1990). Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315-319.
18. J. M. Ervasti and K. P. Campbell (1991). Membrane organization of the dystrophin-glycoprotein complex. Cell 66:1121-1131.
19. O. Ibraghimov-Beskrovnaya, J. M. Ervasti, C. J. Leveille, C. A. Slaughter, S. W. Sernett, and K. P. Campbell (1992). Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702.
20. N. R. Smalheiser and E. Kim (1995). Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties. J. Biol. Chem. 270:15425-15433.
21. S. H. Gee, R. W. Blacher, P. J. Douville, P. R. Provost, P. D. Yurchenco, and S. Carbonetto (1993). Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J. Biol. Chem. 268:14972-14980.
22. M. Durbeej, M. D. Henry, M. Ferletta, K. P. Campbell, and P. Ekblom (1998). Distribution of dystroglycan in normal adult mouse tissues. J. Histochem. Cytochem. 46:449-457.
23. M. Durbeej, E. Larsson, B. O. Ibraghimov, S. L. Roberds, K. P. Campbell, and P. Ekblom (1995). Non-muscle alpha-dystroglycan is involved in epithelial development. J. Cell Biol. 130:79-91.
24. A. M. Belkin and N. R. Smalheiser (1996). Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: Recruitment to focal adhesions is dependent upon extracellular ligands. Cell Adhes. Commun. 4:281-296.
25. M. Durbeej and K. P. Campbell (1999). Biochemical characterization of the epithelial dystroglycan complex. J. Biol. Chem. 274:26609-26616.
26. F. Duclos, V. Straub, S. A. Moore, D. P. Venzke, R. F. Hrstka, R. H. Crosbie, M. Durbeej, C. S. Lebakken, A. J. Ettinger, J. van der Meulen, K. H. Holt, L. E. Lim, J. R. Sanes, B. L. Davidson, J. A. Faulkner, R. Williamson, and K. P. Campbell (1998). Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J. Cell Biol. 142:1461-1471.
27. M. Durbeej, R. D. Cohn, R. F. Hrstka, S. A. Moore, V. Allamand, B. L. Davidson, R. A. Williamson, and K. P. Campbell (2000). Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol. Cell 5:141-151.
28. K. H. Holt, L. E. Lim, V. Straub, D. P. Venzke, F. Duclos, R. D. Anderson, B. L. Davidson, and K. P. Campbell (1998). Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer. Mol. Cell 1:841-848.
29. A. M. Kachinsky, S. C. Froehner, and S. L. Milgram (1999). A PDZ-containing scaffold related to the dystrophin complex at the basolateral membrane of epithelial cells. J. Cell. Biol. 145:391-402.
30. N. Y. Loh, S. E. Newey, K. E. Davies, and D. J. Blake (2000). Assembly of multiple dystrobrevin-containing complexes in the kidney. J. Cell Sci. 113(Pt. 15):2715-2724.
31. M. Durbeej, D. Jung, T. Hjalt, K. P. Campbell, and P. Ekblom (1997). Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis. Dev. Biol. 181:156-167.
32. O. Ibraghimov-Beskrovnaya, A. Milatovich, T. Ozcelik, B. Yang, K. Koepnick, U. Francke, and K. P. Campbell (1993). Human dystroglycan: Skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum. Mol. Genet. 2:1651-1657.
33. C. Losasso, F. Di Tommaso, A. Sgambato, R. Ardito, A. Cittadini, B. Giardina, T. C. Petrucci, and A. Brancaccio (2000). Anomalous dystroglycan in carcinoma cell lines. FEBS Lett. 484:194-198.
34. S. Yotsumoto, H. Fujiwara, J. H. Horton, T. A. Mosby, X. Wang, Y. Cui, and M. S. Ko (1996). Cloning and expression analyses of mouse dystroglycan gene: Specific expression in maternal decidua at the peri-implantation stage. Hum. Mol. Genet. 5:1259-1267.
35. N. J. Dickens, S. Beatson, and C. P. Ponting (2002). Cadherin-like domains in alpha-dystroglycan, alpha/epsilon-sarcoglycan and yeast and bacterial proteins. Curr. Biol. 12:R197-R199.
36. D. Bozic, J. Engel, and A. Brancaccio (1998). Sequence analysis suggests the presence of an IG-like domain in the N-terminal region of alpha-dystroglycan which was crystallized after mutation of a protease susceptible site (Arg168→His). Matrix Biol. 17:495-500.
37. A. Brancaccio, T. Schulthess, M. Gesemann, and J. Engel (1995). Electron microscopic evidence for a mucin-like region in chick muscle alpha-dystroglycan. FEBS Lett. 368:139-142.
38. D. E. Michele, R. Barresi, M. Kanagawa, F. Saito, R. D. Cohn, J. S. Satz, J. Dollar, I. Nishino, R. I. Kelley, H. Somer, V Straub, K. D. Mathews, S. A. Moore, and K. P. Campbell (2002). Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418:417-422.
39. T. Pawson and J. D. Scott (1997). Signaling through scaffold, anchoring, and adaptor proteins. Science 278:2075-2080.
40. J. L. Ilsley, M. Sudol, and S. J. Winder (2001). The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation. Cell. Signal. 13:625-632.
41. M. James, A. Nuttall, J. L. Ilsley, K. Ottersbach, J. M. Tinsley, M. Sudol, and S. J. Winder (2000). Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin. J. Cell Sci. 113(Pt. 10):1717-1726.
42. F. Sotgia, G. Bonuccelli, M. Bedford, A. Brancaccio, U. Mayer, M. T. Wilson, R. Campos-Gonzalez, J. W. Brooks, M. Sudol, and M. P. Lisanti (2003). Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo. Biochemistry 42:7110-7123.
43. M. Bozzi, G. Veglia, M. Paci, F. Sciandra, B. Giardina, and A. Brancaccio (2001). A synthetic peptide corresponding to the 550-585 region of alpha-dystroglycan binds beta-dystroglycan as revealed by NMR spectroscopy. FEBS Lett. 499:210-214.
44. H. Yu and J. F. Talts (2003). beta1 Integrin and alpha-dystroglycan binding sites are localized to different laminin-G-domain-like (LG) modules within the laminin alpha5 chain G domain. Biochem. J. 371:289-299.
45. E. Leygue, L. Snell, H. Dotzlaw, S. Troup, T. Hiller-Hitchcock, L. C. Murphy, P. J. Roughley, and P. H. Watson (2000). Lumican and decorin are differentially expressed in human breast carcinoma. J. Pathol. 192:313-320.
46. C. J. Raats, J. van den Born, M. A. Bakker, B. Oppers-Walgreen, B. J. Pisa, H. B. Dijkman, K. J. Assmann, and J. H. Berden (2000). Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am. J. Pathol. 156:1749-1765.
47. R. Timpl, D. Tisi, J. F. Talts, Z. Andac, T. Sasaki, and E. Hohenester (2000). Structure and function of laminin LG modules. Matrix Biol. 19:309-317.
48. E. A. Pall, K. M. Bolton, and J. M. Ervasti (1996). Differential heparin inhibition of skeletal muscle alpha-dystroglycan binding to laminins. J. Biol. Chem. 271:3817-3821.
49. D. Tisi, J. F. Talts, R. Timpl, and E. Hohenester (2000). Structure of the C-terminal laminin G-like domain pair of the laminin alpha2 chain harbouring binding sites for alpha-dystroglycan and heparin. EMBO J. 19:1432-1440.
50. N. Suzuki, H. Nakatsuka, M. Mochizuki, N. Nishi, Y. Kadoya, A. Utani, S. Oishi, N. Fujii, H. K. Kleinman, and M. Nomizu (2003). Biological activities of homologous loop regions in the laminin alpha chain G domains. J. Biol. Chem. 278:45697-45705.
51. B. Yang, D. Jung, D. Motto, J. Meyer, G. Koretzky, and K. P. Campbell (1995). SH3 domain-mediated interaction of dystroglycan and Grb2. J. Biol. Chem. 270:11711-11714.
52. M. Cavaldesi, G. Macchia, S. Barca, P. Defilippi, G. Tarone, and T. C. Petrucci (1999). Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction. J. Neurochem. 72:1648-1655.
53. K. Russo, E. Di Stasio, G. Macchia, G. Rosa, A. Brancaccio, and T. C. Petrucci (2000). Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction. Biochem. Biophys. Res. Commun. 274:93-98.
54. J. L. Ilsley, M. Sudol, and S. J. Winder (2002). The WW domain: Linking cell signalling to the membrane cytoskeleton. Cell. Signal. 14:183-189.
55. F. Sotgia, H. Lee, M. T. Bedford, T. Petrucci, M. Sudol, and M. P. Lisanti (2001). Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 40:14585-14592.
56. J. T. Anderson, R. P. Rogers, and H. W. Jarrett (1996). Ca2+-calmodulin binds to the carboxyl-terminal domain of dystrophin. J. Biol. Chem. 271:6605-6610.
57. A. Tommasi di Vignano, G. Di Zenzo, M. Sudol, G. Cesareni, and L. Dente (2000). Contribution of the different modules in the utrophin carboxy-terminal region to the formation and regulation of the DAP complex. FEBS Lett. 471:229-234.
58. F. Sotgia, J. K. Lee, K. Das, M. Bedford, T. C. Petrucci, P. Macioce, M. Sargiacomo, F. D. Bricarelli, C. Minetti, M. Sudol, and M. P. Lisanti (2000). Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J. Biol. Chem. 275:38048-38058.
59. D. S. Park, H. Lee, C. Riedel, J. Hulit, P. E. Scherer, R. G. Pestell, and M. P. Lisanti (2001). Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. J. Biol. Chem. 276:48389-48397.
60. Y. J. Chen, H. J. Spence, J. M. Cameron, T. Jess, J. L. Ilsley, and S. J. Winder (2003). Direct interaction of beta-dystroglycan with F-actin. Biochem. J. 375:329-337.
61. A. Cartaud, S. Coutant, T. C. Petrucci, and J. Cartaud (1998). Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse. J. Biol. Chem. 273:11321-11326.
62. L. S. Musil, D. E. Frail, and J. P. Merlie (1989). The mammalian 43-kD acetylcholine receptor-associated protein (RAPsyn) is expressed in some nonmuscle cells. J. Cell Biol. 108:1833-1840.
63. R. A. Williamson, M. D. Henry, K. J. Daniels, R. F. Hrstka, J. C. Lee, Y. Sunada, B. O. Ibraghimov, and K. P. Campbell (1997). Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice. Hum. Mol. Genet. 6:831-841.
64. P. D. Cote, H. Moukhles, M. Lindenbaum, and S. Carbonetto (1999). Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat. Genet. 23:338-342.
65. R. D. Cohn, M. D. Henry, D. E. Michele, R. Barresi, F. Saito, S. A. Moore, J. D. Flanagan, M. W. Skwarchuk, M. E. Robbins, J. R. Mendell, R. A. Williamson, and K. P. Campbell (2002). Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110:639-648.
66. S. A. Moore, F. Saito, J. Chen, D. E. Michele, M. D. Henry, A. Messing, R. D. Cohn, S. E. Ross-Barta, S. Westra, R. A. Williamson, T. Hoshi, and K. P. Campbell (2002). Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418:422-425.
67. W. M. Deng, M. Schneider, R. Frock, C. Castillejo-Lopez, E. A. Gaman, S. Baumgartner, and H. Ruohola-Baker (2003). Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila. Development 130:173-184.
68. M. Durbeej, J. F. Talts, M. D. Henry, P. D. Yurchenco, K. P. Campbell, and P. Ekblom (2001). Dystroglycan binding to laminin alpha1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. Differentiation 69:121-134.
69. Y. Kadoya, K. Kadoya, M. Durbeej, K. Holmvall, L. Sorokin, and P. Ekblom (1995). Antibodies against domain E3 of laminin-1 and integrin alpha 6 subunit perturb branching epithelial morphogenesis of submandibular gland, but by different modes. J. Cell Biol. 129:521-534.
70. S. Li, D. Edgar, R. Fassler, W. Wadsworth, and P. D. Yurchenco (2003). The role of laminin in embryonic cell polarization and tissue organization. Dev. Cell 4:613-624.
71. M. D. Henry and K. P. Campbell (1998). A role for dystroglycan in basement membrane assembly. Cell 95:859-870.
72. S. Li, D. Harrison, S. Carbonetto, R. Fassler, N. Smyth, D. Edgar, and P. D. Yurchenco (2002). Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J. Cell Biol. 157:1279-1290.
73. H. Colognato, D. A. Winkelmann, and P. D. Yurchenco (1999). Laminin polymerization induces a receptor-cytoskeleton network. J. Cell Biol. 145:619-631.
74. 1 integrin and perlecan in cell surface laminin organization. J. Cell Sci. 114:1137-1144.
75. V. M. Weaver, O. W. Petersen, F. Wang, C. A. Larabell, P. Briand, C. Damsky, and M. J. Bissell (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137:231-245.
76. M. Ferletta, Y. Kikkawa, H. Yu, J. F. Talts, M. Durbeej, A. Sonnenberg, R. Timpl, K. P. Campbell, P. Ekblom, and E. Genersch (2003). Opposing roles of integrin alpha6Abeta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation. Mol. Biol. Cell 14:2089-2103.
77. M. D. Henry, M. B. Cohen, and K. P. Campbell (2001). Reduced expression of dystroglycan in breast and prostate cancer. Hum. Pathol. 32:791-795.
78. A. Sgambato, M. Migaldi, M. Montanari, A. Camerini, A. Brancaccio, G. Rossi, R. Cangiano, C. Losasso, G. Capelli, G. P. Trentini, and A. Cittadini (2003). Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am. J. Pathol. 162:849-860.
79. K. Matsumura, A. Chiba, H. Yamada, H. Fukuta-Ohi, S. Fujita, T. Endo, A. Kobata, L. V. Anderson, I. Kanazawa, K. P. Campbell, and T. Shimizu (1997). A role of dystroglycan in schwannoma cell adhesion to laminin. J. Biol. Chem. 272:13904-13910.
80. H. Shimizu, H. Hosokawa, H. Ninomiya, J. H. Miner, and T. Masaki (1999). Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan. J. Biol. Chem. 274:11995-12000.
81. H. Yamada, F. Saito, H. Fukuta-Ohi, D. Zhong, A. Hase, K. Arai, A. Okuyama, R. Maekawa, T. Shimizu, and K. Matsumura (2001). Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum. Mol. Genet. 10:1563-1569.